<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01781130</url>
  </required_header>
  <id_info>
    <org_study_id>2012-11-112-002</org_study_id>
    <nct_id>NCT01781130</nct_id>
  </id_info>
  <brief_title>Effect of Steroid Injection Which is Added to Percutaneous Trigger Finger Release: a Double-blinded Randomized Controlled Trial.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background&#xD;
&#xD;
      Present treatment strategies for trigger finger when conservative management including&#xD;
      steroid injection was failed include percutaneous or open A1 pulley release, but some people&#xD;
      showed prolonged swelling and delay of complete healing.&#xD;
&#xD;
      We aimed to test the hypothesis that an improved outcome can be achieved by employing steroid&#xD;
      injection simultaneously with percutaneous release compared with conventional percutaneous&#xD;
      release alone&#xD;
&#xD;
      Methods&#xD;
&#xD;
      We designed a double-blind, randomized controlled trial.&#xD;
&#xD;
      Inclusion criteria is the patient who has symptom of trigger finger warranted surgical&#xD;
      release after sufficient time of conservative treatment.&#xD;
&#xD;
      Exclusion criteria are as follow: 1) multiple fingers at presentation; 2) Rheumatoid&#xD;
      arthritis patients; 3) Pregnant or lactating patients; 4) Younger than 18 years old; 5)&#xD;
      Previous surgery history of finger 6); the patients who got steroid injection more than 4&#xD;
      time previously; 7) coagulation abnormality including usage of anti-thrombotic agent.&#xD;
&#xD;
      After power analysis by a statistician, total 40 patients would be required for each group&#xD;
      (percutaneous alone group versus percutaneous alone + steroid injection group).&#xD;
&#xD;
      The surgery will be performed by outpatients clinic basis with local injection. Additional&#xD;
      steroid injection will be given to half of patients after allocation with randomized&#xD;
      selection by permutaed block randomization.&#xD;
&#xD;
      Primary outcome measure is mean fall in pain visual analogue scale (pVAS) and secondary&#xD;
      outcome will be proportion of patients with good response (defined as &quot;Perfect&quot; or &quot;much&#xD;
      better&quot; as reported by patients).&#xD;
&#xD;
      Follow-up will be conducted 3 weeks and 3 month after index procedure&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain VAS</measure>
    <time_frame>3 month after procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Trigger Finger</condition>
  <arm_group>
    <arm_group_label>Percutaneous release alone</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The patients who perform percutaneous release of trigger finger only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous release + Steroid injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Steroid local injection after percutaneous release of trigger finger</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Steroid injection</intervention_name>
    <arm_group_label>Percutaneous release + Steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Trigger finger patients who require surgical intervention due to failuer of sufficient&#xD;
             time of conservative treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years old&#xD;
&#xD;
          -  Rheumatoid arthritis patients&#xD;
&#xD;
          -  Patients who got steroid injection more than 4 times previously&#xD;
&#xD;
          -  Multiple finger affected at presentation&#xD;
&#xD;
          -  Previous surgery history&#xD;
&#xD;
          -  Any recent trauma history of affected hand&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Patel MR, Moradia VJ. Percutaneous release of trigger digit with and without cortisone injection. J Hand Surg Am. 1997 Jan;22(1):150-5.</citation>
    <PMID>9018629</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>January 15, 2013</study_first_submitted>
  <study_first_submitted_qc>January 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2013</study_first_posted>
  <last_update_submitted>May 15, 2015</last_update_submitted>
  <last_update_submitted_qc>May 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Min Jong Park</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigger Finger Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

